Who are Natrecor's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Monoket, Sodium Nitroprusside, nitroglycerine, Atriopeptin, rhBNP, recombinant human BNP(1-32).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/nesiritide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Natrecor — Competitive Intelligence Brief

Natrecor (NESIRITIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natriuretic Peptide. Area: Cardiovascular.

marketed Natriuretic Peptide Atrial natriuretic peptide receptor 1 Cardiovascular Recombinant protein Live · refreshed every 30 min

Target snapshot

Natrecor (NESIRITIDE) — Scios Llc.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Natrecor TARGET	NESIRITIDE	Scios Llc	marketed	Natriuretic Peptide	Atrial natriuretic peptide receptor 1	2001-01-01
Monoket	ISOSORBIDE MONONITRATE		marketed	Nitrate Vasodilator [EPC]	Atrial natriuretic peptide receptor 1	1991-01-01
Sodium Nitroprusside	NITROPRUSSIDE	Roche	marketed	Vasodilator	Atrial natriuretic peptide receptor 1	1974-01-01
nitroglycerine	nitroglycerine	University Hospital, Ghent	marketed		Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase
Atriopeptin	CARPERITIDE		phase 3	carperitide	Atrial natriuretic peptide receptor 1, Atrial natriuretic peptide receptor 1
rhBNP	rhBNP	LI ZHAO	marketed	Natriuretic peptide	Natriuretic peptide receptor-A (NPR-A)
recombinant human BNP(1-32)	recombinant human BNP(1-32)	VA Office of Research and Development	marketed	Natriuretic peptide	Natriuretic peptide receptor-A (NPR-A)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natriuretic Peptide class)

Scios Llc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Natrecor — Competitive Intelligence Brief. https://druglandscape.com/ci/nesiritide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab